Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value:
$2.27B
Total Bought:
$714.40M
Total Sold:
$564.96M
Net Transaction:
+$149.44M
Notable People:
Bihua Chen, Cormorant Asset Management Gp,
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)8,494,1518,494,1510$512.96M$426.66M18.80%-$86.30M
EyePoint, Inc.(EYPT)6,038,2356,893,235+855,000$139.54M$142.48M6.28%+$2.94M
Arcellx Inc
COMMON STOCK
1,700,0001,780,000+80,000$94.35M$123.80M5.45%+$29.45M
Alpine Immune Sciences Inc2,550,0002,700,000+150,000$48.60M$107.03M4.72%+$58.42M
BridgeBio Pharma, Inc.(BBIO)3,344,1793,203,029-141,150$135.00M$99.04M4.36%-$35.97M
Praxis Precision Medicines, Inc.(PRAX)633,3451,310,000+676,655$14.11M$79.94M3.52%+$65.83M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)02,025,000+2,025,000$0$79.46M3.50%+$79.46M
Tarsus Pharmaceuticals, Inc.(TARS)2,221,4222,139,102-82,320$44.98M$77.76M3.43%+$32.77M
Longboard Pharmaceuticals In2,353,1413,353,141+1,000,000$14.19M$72.43M3.19%+$58.24M
Edgewise Therapeutics, Inc.(EWTX)2,551,9893,006,534+454,545$27.92M$54.84M2.42%+$26.92M
Crinetics Pharmaceuticals In1,150,0001,150,0000$40.92M$53.83M2.37%+$12.91M
Biomea Fusion, Inc.(BMEA)3,570,8723,570,8720$51.85M$53.38M2.35%+$1.54M
Korro Bio, Inc.(KRRO)529,170529,1700$25.36M$47.63M2.10%+$22.26M
Vaxcyte, Inc.(PCVX)665,000685,000+20,000$41.76M$46.79M2.06%+$5.03M
Autolus Therapeutics plcADS(AUTL)5,450,0006,616,667+1,166,667$35.10M$42.21M1.86%+$7.12M
Pharvaris N V
COM
1,711,4601,711,4600$48.01M$39.55M1.74%-$8.45M
Newamsterdam Pharma Company
ORDINARY SHARES
01,500,000+1,500,000$0$35.48M1.56%+$35.48M
CG Oncology, Inc.(CGON)0800,000+800,000$0$35.12M1.55%+$35.12M
ALX Oncology Holdings Inc.(ALXO)3,142,0793,142,0790$46.79M$35.03M1.54%-$11.75M
Biohaven Ltd.(BHVN)81,963616,963+535,000$3.51M$33.74M1.49%+$30.23M
Merus N V0715,000+715,000$0$32.20M1.42%+$32.20M
Aerovate Therapeutics Inc1,211,6961,069,796-141,900$27.42M$31.63M1.39%+$4.21M
ABIVAX Société AnonymeADS(ABVX)2,130,0002,130,0000$22.79M$30.46M1.34%+$7.67M
Helix Acquisition Corp IiCL A02,909,000+2,909,000$0$30.25M1.33%+$30.25M
Marinus Pharmaceuticals Inc3,250,0003,250,0000$35.33M$29.38M1.29%-$5.95M
Tourmaline Bio Inc01,250,000+1,250,000$0$28.63M1.26%+$28.63M
Janux Therapeutics, Inc.(JANX)0750,000+750,000$0$28.24M1.24%+$28.24M
Neurogene Inc.(NGNE)746,180538,714-207,466$14.46M$27.42M1.21%+$12.96M
Cargo Therapeutics Inc1,182,5631,182,5630$27.38M$26.39M1.16%-$981.5K
Rhythm Pharmaceuticals, Inc.(RYTM)550,000550,0000$25.28M$23.83M1.05%-$1.45M
Apellis Pharmaceuticals Inc
COM
625,000400,000-225,000$37.41M$23.51M1.04%-$13.90M
Arcutis Biotherapeutics, Inc.(ARQT)02,125,000+2,125,000$0$21.06M0.93%+$21.06M
IDEAYA Biosciences, Inc.(IDYA)450,000450,0000$16.01M$19.75M0.87%+$3.73M
Cabaletta Bio, Inc.(CABA)01,100,000+1,100,000$0$18.77M0.83%+$18.77M
Astria Therapeutics Inc01,300,000+1,300,000$0$18.30M0.81%+$18.30M
Engene Holdings Inc
COM
01,000,000+1,000,000$0$16.95M0.75%+$16.95M
Insmed Incorporated(INSM)575,000575,0000$17.82M$15.60M0.69%-$2.22M
Ventyx Biosciences Inc02,710,000+2,710,000$0$14.90M0.66%+$14.90M
Nkarta, Inc.(NKTX)01,350,000+1,350,000$0$14.59M0.64%+$14.59M
Silence Therapeutics plcADS(SLN)0625,000+625,000$0$13.50M0.59%+$13.50M
Mersana Therapeutics Inc02,600,000+2,600,000$0$11.65M0.51%+$11.65M
Compass Therapeutics, Inc.(CMPX)05,560,300+5,560,300$0$11.01M0.49%+$11.01M
Kyverna Therapeutics, Inc.(KYTX)0440,000+440,000$0$10.93M0.48%+$10.93M
Immuneering CorpCL A4,204,3643,295,273-909,091$30.90M$9.52M0.42%-$21.38M
Spyre Therapeutics, Inc.(SYRE)937,080250,000-687,080$20.17M$9.48M0.42%-$10.68M
ArriVent BioPharma, Inc.(AVBP)0515,000+515,000$0$9.20M0.41%+$9.20M
Rocket Pharmaceuticals, Inc.(RCKT)450,000300,000-150,000$13.49M$8.08M0.36%-$5.40M
Disc Medicine, Inc.(IRON)125,000125,0000$7.22M$7.78M0.34%+$562.5K
Centessa Pharmaceuticals PlcADS561,600561,6000$4.47M$6.35M0.28%+$1.88M
GH Research PLC(GHRS)593,043593,0430$3.44M$6.32M0.28%+$2.88M
Stoke Therapeutics, Inc.(STOK)1,087,807427,163-660,644$5.72M$5.77M0.25%+$44.8K
Lantheus Holdings, Inc.(LNTH)75,00075,0000$4.65M$4.67M0.21%+$18.0K
Verve Therapeutics Inc350,000350,0000$4.88M$4.65M0.20%-$231.0K
Rapt Therapeutics Inc496,750496,7500$12.34M$4.46M0.20%-$7.88M
Yarrow Bioscience Inc(YARW)1,394,3361,394,3360$3.25M$4.28M0.19%+$1.03M
BioAtla, Inc.(BCAB)1,181,1151,170,870-10,245$2.91M$4.03M0.18%+$1.12M
Ambrx Biopharma Inc11,231,0000-11,231,000$159.93M$0—-$159.93M
Axonics Inc250,0000-250,000$15.56M$0—-$15.56M
Cymabay Therapeutics Inc1,800,0000-1,800,000$42.52M$0—-$42.52M
Harpoon Therapeutics Inc2,349,0600-2,349,060$22.55M$0—-$22.55M
Immunovant, Inc.(IMVT)1,165,0000-1,165,000$49.08M$0—-$49.08M
Neumora Therapeutics, Inc.(NMRA)92,2930-92,293$1.57M$0—-$1.57M
Olema Pharmaceuticals, Inc.(OLMA)2,456,8000-2,456,800$34.47M$0—-$34.47M
Rayzebio Inc1,213,4780-1,213,478$75.44M$0—-$75.44M
Syndax Pharmaceuticals, Inc.(SNDX)1,175,0000-1,175,000$25.39M$0—-$25.39M
Page 1 of 1